Marie O’Farrell
Company: Sagimet Biosciences
Job title: Senior Vice President - Research & Development
Seminars:
3.15 pm Panel Discussion: Designing Therapies with Novel Mechanisms & Predictive Biomarkers to Holistically Improve Treatment for Better Patient Outcomes 3:15 pm
Integrating the design of therapies involving novel mechanisms with new, predictive biomarkers to provide a more precise and efficient approach to drug discovery and development for earlier identification of responders and non-responders Leveraging cutting-edge understanding of MASH pathogenesis to design innovative therapies to target the root causes of the disease for more effective treatments that…Read more
day: Combination & Sequential Therapy Focus Day
2:45 pmHighlighting Mechanism of Action of FASN Inhibitor Denifanstat in MASH 2:45 pm
Reviewing preclinical activity of FASN inhibitor combined with semaglutide or resmetirom Highlighting efficacy of denifanstat added to background GLP1 treatment in Ph2b FASCINATE-2 Planning Phase 1 PK assessment of denifanstat and resmetiromRead more
day: Combination & Sequential Therapy Focus Day